Cadila Healthcare jumps after strong Q4 results

Cadila Healthcare rose 3.55% to Rs 1,717 at 14:00 IST on BSE after consolidated net profit rose 46.48% to Rs 350.38 crore on 16.49% growth in total income to Rs 2308.57 crore in Q4 March 2015 over Q4 March 2014.

The Q4 result was announced during market hours today, 15 May 2015.

Meanwhile, the S&P BSE Sensex was up 131.70 points or 0.48% at 27,337.76.

On BSE, so far 73,000 shares were traded in the counter as against average daily volume of 19,827 shares in the past one quarter.

The stock hit a high of Rs 1,767 and a low of Rs 1,670 so far during the day. The stock had hit a record high of Rs 1,998 on 7 April 2015. The stock had hit a 52-week low of Rs 872.55 on 19 May 2014.

The stock had underperformed the market over the past one month till 14 May 2015, sliding 7.17% compared with Sensex's 6.33% fall. The scrip had, however, outperformed the market in past one quarter, advancing 4.07% as against Sensex's 6.49% fall.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Rs 5.

Cadila Healthcare's gross sales rose 18% to Rs 2297 crore in Q4 March 2015 over Q4 March 2014.

Cadila Healthcare's board of directors recommended dividend of Rs 12 per share for the year ended 31 March 2015.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News